Literature DB >> 8582440

Quantitation of levamisole in plasma using high performance liquid chromatography.

T F Vandamme1, M Demoustier, B Rollmann.   

Abstract

A rapid and sensitive procedure is described for the quantitation of levamisole in plasma using high-performance liquid chromatography (HPLC). The procedure involves sample preparation using a reverse-phase C18 cartridge prior to chromatography and quantitation using peak area ratios (UV absorbance detection, 225 nm) of levamisole to the internal standard, quinine. The limit of detection was 21 ng/ml and the limit of quantification was 72 ng/ml, both contained in 1 ml of plasma. The recoveries were sufficiently high (73.1%) and overall coefficient of variation of the procedure was 0.25%. This procedure has been used to determine levamisole levels in human and cattle plasma. A comparison of using two C18 columns (Nova-pak, Puresil) was also studied and discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582440     DOI: 10.1007/BF03226369

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  Field and controlled test evaluation of levamisole against natural infections of gastrointestinal nematodes and lungworms in calves.

Authors:  E T Lyons; J H Drudge; D E Labore; S C Tolliver
Journal:  Am J Vet Res       Date:  1972-01       Impact factor: 1.156

2.  Determination of the anthelmintic levamisole in plasma and gastro-intestinal fluids by high-performance liquid chromatography.

Authors:  S Marriner; E A Galbraith; J A Bogan
Journal:  Analyst       Date:  1980-10       Impact factor: 4.616

3.  [Immunostimulating effect of an imidotiiazole in the immunization of mice against Brucella abortus infection].

Authors:  G Renoux; M Renoux
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1971-01-11

4.  Novel broad-spectrum anthelmintics. Tetramisole and related derivatives of 6-arylimidazo[2,1-b]thiazole.

Authors:  A H Raeymaekers; F T Allewijn; J Vandenberk; P J Demoen; T T Van Offenwert; P A Janssen
Journal:  J Med Chem       Date:  1966-07       Impact factor: 7.446

5.  Gas-liquid chromatographic determination of levamisole residues in bovine milk.

Authors:  J E Smith; N R Pasarela; J C Wyckoff
Journal:  J Assoc Off Anal Chem       Date:  1976-09

6.  Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection.

Authors:  R Woestenborghs; L Michielsen; J Heykants
Journal:  J Chromatogr       Date:  1981-06-12

7.  Gas-chromatographic determination of levamisole in human plasma-normalization and reliability of the method.

Authors:  F Rousseau; J M Haguenoer; D Lesieur; A P Gamot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

8.  Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.

Authors:  J S Kovach; P A Svingen; D J Schaid
Journal:  J Natl Cancer Inst       Date:  1992-04-01       Impact factor: 13.506

9.  [Therapeutical trial in ascariasis with a single dose of a new anthelmintic drug (R-8299 or Tetramisole)].

Authors:  O B do Nascimento Filha; M Halsman; H Oria; J V Campos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1966 May-Jun       Impact factor: 1.846

  9 in total
  3 in total

1.  Development of RP-HPLC Method for the Simultaneous Quantitation of Levamisole and Albendazole: Application to Assay Validation.

Authors:  S Sowjanya; Ch Devadasu
Journal:  Int J Anal Chem       Date:  2018-07-02       Impact factor: 1.885

2.  Quantitative Analysis of Abamectin, Albendazole, Levamisole HCl and Closantel in Q-DRENCH Oral Suspension Using a Stability-Indicating HPLC-DAD Method.

Authors:  Hazim M Ali; Mohammed Gamal; Mohammed M Ghoneim; Lobna Mohammed Abd Elhalim
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

3.  Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia.

Authors:  Richard J Maude; Kamolrat Silamut; Katherine Plewes; Prakaykaew Charunwatthana; May Ho; M Abul Faiz; Ridwanur Rahman; Md Amir Hossain; Mahtab U Hassan; Emran Bin Yunus; Gofranul Hoque; Faridul Islam; Aniruddha Ghose; Josh Hanson; Joel Schlatter; Rachel Lacey; Alison Eastaugh; Joel Tarning; Sue J Lee; Nicholas J White; Kesinee Chotivanich; Nicholas P J Day; Arjen M Dondorp
Journal:  J Infect Dis       Date:  2013-08-13       Impact factor: 5.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.